Key result
Fibro-calcific stenotic valve cells exhibit increased RNA modification sites compared to non-calcified controls.
Why the study?
Calcific aortic valve disease lacks effective medical therapies, and how chemical RNA modifications influence the shift of valve cells toward fibro-calcific states remains incompletely understood.
Does RNA modification remodeling occur in human valvular interstitial cells from fibro-calcific aortic valves compared to non-calcified valves?
Observational
Does RNA modification remodeling occur in human valvular interstitial cells from fibro-calcific aortic valves compared to non-calcified valves?
The study identifies disease-associated RNA modification remodeling in calcific aortic valve disease, highlighting potential targets for non-surgical therapeutic exploration.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for RNA modification-targeted therapies in calcific aortic valve disease; leaves open causal role and clinical utility.
Calcific aortic valve disease is common in older adults and a major cause of aortic stenosis. Despite its clinical impact, there are still no effective drugs that slow disease progression, and treatment largely relies on surgical or transcatheter valve replacement once stenosis becomes severe and symptomatic. Beyond established roles for inflammation and tissue remodeling, recent evidence suggests that chemical modifications of RNA may influence how valve cells shift toward fibro-calcific states. In this study, we compared human valvular interstitial cells isolated from non-calcified valves and from fibro-calcific stenotic valves, profiling RNA modifications using direct RNA sequencing. The resulting epitranscriptomic patterns clearly separated control from diseased cells and revealed an overall increase in detected modification sites in disease, alongside site-specific gains and losses across selected transcripts. Network-based prioritization highlighted genes linked to extracellular matrix remodeling and inflammatory signaling, pointing to stress-responsive regulators as notable candidates. Overall, these findings support the idea that disease-associated RNA modification remodeling accompanies, and may help shape, key cellular programs in calcific valve disease, providing a focused set of targets for future functional validation and potential non-surgical therapeutic exploration.
No takes yet. Share an insight, caveat, or question.
Valerio et al. (2026) conducted an observational in Calcific aortic valve disease. Fibro-calcific aortic valve disease vs. Non-calcified valves was evaluated on RNA modification patterns (epitranscriptomic patterns). Human valvular interstitial cells from fibro-calcific stenotic valves exhibited an overall increase in RNA modification sites compared to non-calcified controls.
Synapse has enriched 10 related papers. Consider them for comparative context: